Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that bind LGR4, their use in inhibiting neoplastic cells and in treating tumors

Antibodies that bind LGR4, their use in inhibiting neoplastic cells and in treating tumors

US Patent 9631024 · Granted Apr 25, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody and checkpoint inhibitor combination therapy2023
Method of treating cancer by administering an anti-LGR5 monoclonal antibody2020
Method of treating cancer by administering an anti-LGR5 monoclonal antibody2020
Methods of blocking cancer stem cell growth2020
Methods of blocking cancer stem cell growth2020
Humanized antibodies that bind LGR52019
Humanized antibodies that bind LGR52019
Humanized antibodies that bind LGR52019
Humanized antibodies that bind LGR52019
Methods of inhibiting growth of a colon cancer tumor in a subject by administeri2019
Methods of inhibiting growth of a colon cancer tumor in a subject by administeri2019
Methods for sensitizing a quiescent cancer stem cell to a BCR-ABL inhibitor2018